Defunct Company
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
21
NCT00671554
Trial of Melaxin Cancer Vaccine Plus Bacillus Calmette-Guerin (BCG) to Treat Malignant Melanoma
Phase: Phase 1/2
Role: Collaborator
Start: Apr 30, 2008
Completion: Mar 31, 2009
NCT02534922
Study of Prolanta™ in Recurrent or Persistent Epithelial Ovarian Cancer
Phase: Phase 1
Role: Lead Sponsor
Start: Feb 29, 2016
Completion: Feb 28, 2019